Puma Biotechnology Inc (PBYI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $401.70M
Last updated: Nov 17, 2026 at 11:06 AM ET
Puma Biotechnology Inc (PBYI) Stock Forecast
Analysts expect Puma Biotechnology (PBYI) to earn $0.55 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is $0.35.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 36.4%.
- Fiscal year ending Dec 31, 2026
- $0.55
- EPS consensus
- Fiscal year ending Dec 31, 2027
- $0.35
- EPS consensus
- Next report
- Feb 24, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | $0.55 | $0.55 to $0.55 | 1 |
| Dec 31, 2027 | $0.35 | $0.35 to $0.35 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.23 | $0.23 to $0.24 | 3 | $68.54M | $65.86M to $70.56M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 22.2% from $0.45.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.55 | $0.45 | $0.45 | $0.45 | $0.45 | +22.2% |
| Fiscal year ending Dec 31, 2027 | $0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 0.0% |
Frequently Asked Questions About PBYI
What is the PBYI stock forecast?
Consensus analyst estimates put Puma Biotechnology's EPS at $0.55 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from PBYI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.55, with estimates from $0.55 to $0.55 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.35, with estimates from $0.35 to $0.35 from 1 analyst.
How many analysts cover PBYI?
1 analyst estimates EPS for Puma Biotechnology for the fiscal year ending Dec 31, 2026.
PBYI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors